High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.
NCT ID: NCT06247423
Last Updated: 2024-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2024-02-02
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Compare the effectiveness between sham stimulation and real stimulation (10kHz) for different types of tremors \[rest tremor, postural tremor, kinetic tremor\], fine motor skills, and maximal isometric handgrip strength.
* Register adverse events, the blinding success of participants and evaluator, and subjective perception of tremor improvement.
Participants will perform the following tasks in an "off" state (without levodopa and dopamine agonists medication). All of them were performed on the upper limb with more tremor.
* Rest Tremor: Forearm on the armrest, count backward from 100 to 0 as fast as possible for 1 minute and 30 seconds.
* Postural Tremor: Extend the arm parallel to the floor (90º shoulder flexion with the forearm extended) for 30 seconds.
* Kinetic Tremor: Hold a cup by the handle, raise it close to the mouth for 3 seconds, then return to the initial position.
* Fine Motor Skills: Complete the nine-hole peg test, placing pegs into holes as quickly as possible.
* Handgrip Strength: Squeeze the device as strongly as possible for 3 seconds, then rest for 15 seconds.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Motor Network in Essential Tremor: Mechanisms of Therapy
NCT02712515
24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor
NCT06570421
The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients
NCT02947841
Physiology, Imaging and Modeling of Essential Tremor
NCT03811405
Sub-thalamic Nucleus Stimulation in Parkinson Disease
NCT01817088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For these reasons, tremor-related pathologies could benefit from HFAC stimulation. To our knowledge, no studies have applied HFAC stimulation in patients with PD. The main objective of this study is to compare the effectiveness of sham stimulation and real stimulation (10kHz) for tremor \[rest tremor, postural tremor, kinetic tremor\] in people with PD. Secondary objectives include analyzing the effectiveness of stimulation for fine motor skills and maximal isometric grip strength in people with PD, as well as documenting adverse events and evaluating blinding success.
A double-blind, randomized, crossover-design study will be conducted at the University of Castilla-La Mancha. Two interventions will be performed in people with Parkinson's Disease during "Off" state, randomizing the order: Intervention A: 10kHz stimulation; Intervention B: sham electrical stimulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
* Intervention A: active stimulation (High-frequency current stimulation 10kHz).
* Intervention B: sham stimulation (simulated electrical stimulation).
TREATMENT
DOUBLE
Blinding of the outcome assessor will be performed using different team members for randomization of the interventions (Researcher 1), intervention (Researcher 2), evaluation (Researcher 3), and statistical analysis (Researcher 4). Randomization will be kept hidden from participants and research team members and only the researcher who will deliver the intervention (Researcher 2) will know the group assignment. Successful blinding of participants and evaluator will be analyzed.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
10kHz
Alternating current stimulation with a 10kHz frequency with a transcutaneous approach, 20 minutes for each intervention.
Active group 10kHz
For electrical stimulation in the active groups, unmodulated alternating currents with a symmetrical rectangular waveform of 10 kHz will be applied for 20 minutes. The current intensity shall be adjusted individually for each participant by increasing the current intensity until the participant reports a "strong but comfortable tingling" sensation just below the motor threshold. One electrode will be placed over the median and radial nerves, while the other over the radial nerve.
The intensity of the current shall be adjusted every two minutes if the tingling sensation decreases. This protocol had been used in previous studies conducted by our research group.
Sham stimulation
Sham stimulation via transcutaneous approach will be delivered only for the first 30 seconds, following the same procedures as the 10kHz group.
Sham intervention
Sham electrical stimulation will be performed with the same equipment, time, and electrodes as in the active groups without the participants and the evaluator having a view of the device screen. The intensity of the current will be increased for 30 seconds until the sensory threshold ("strong but comfortable tingling sensation") will be reached and after that, the intensity will be reduced to 0 milliamperes (mA) with 30 seconds ramp down. Participants will not receive electrical current during the rest of the placebo intervention. This protocol was used in other studies with similar interventions to blind participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active group 10kHz
For electrical stimulation in the active groups, unmodulated alternating currents with a symmetrical rectangular waveform of 10 kHz will be applied for 20 minutes. The current intensity shall be adjusted individually for each participant by increasing the current intensity until the participant reports a "strong but comfortable tingling" sensation just below the motor threshold. One electrode will be placed over the median and radial nerves, while the other over the radial nerve.
The intensity of the current shall be adjusted every two minutes if the tingling sensation decreases. This protocol had been used in previous studies conducted by our research group.
Sham intervention
Sham electrical stimulation will be performed with the same equipment, time, and electrodes as in the active groups without the participants and the evaluator having a view of the device screen. The intensity of the current will be increased for 30 seconds until the sensory threshold ("strong but comfortable tingling sensation") will be reached and after that, the intensity will be reduced to 0 milliamperes (mA) with 30 seconds ramp down. Participants will not receive electrical current during the rest of the placebo intervention. This protocol was used in other studies with similar interventions to blind participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must possess adequate cognitive capacity to perform the tests and understand all the procedure.
* Tolerance to the application of electrotherapy.
Exclusion Criteria
* Altered sensitivity in the intervention area
* Recent traumatism or surgeries which interfere with the measures
* Presence of pacemakers or other implanted electrical devices
* Tattoos or other external agents in the treatment area
* Comorbidities or conditions affecting tremor or coordination (cerebellar injury)
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Science and Innovation, Spain
OTHER_GOV
Asociación Parkinson Toledo (CAP Toledo)
UNKNOWN
University of Castilla-La Mancha
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julio Gómez-Soriano, PhD
Role: PRINCIPAL_INVESTIGATOR
Toledo Physiotherapy Research Group (GIFTO). Castilla la Mancha University.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Castilla La Mancha
Toledo, Toledo, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arruda BS, Reis C, Sermon JJ, Pogosyan A, Brown P, Cagnan H. Identifying and modulating distinct tremor states through peripheral nerve stimulation in Parkinsonian rest tremor. J Neuroeng Rehabil. 2021 Dec 25;18(1):179. doi: 10.1186/s12984-021-00973-6.
Jitkritsadakul O, Thanawattano C, Anan C, Bhidayasiri R. Tremor's glove-an innovative electrical muscle stimulation therapy for intractable tremor in Parkinson's disease: A randomized sham-controlled trial. J Neurol Sci. 2017 Oct 15;381:331-340. doi: 10.1016/j.jns.2017.08.3246. Epub 2017 Aug 24.
Contreras VT, Araque W, Delgado VS. Trypanosoma cruzi: metacyclogenesis in vitro--I. Changes in the properties of metacyclic trypomastigotes maintained in the laboratory by different methods. Mem Inst Oswaldo Cruz. 1994 Apr-Jun;89(2):253-9. doi: 10.1590/s0074-02761994000200026.
Related Links
Access external resources that provide additional context or updates about the study.
We used the references explained on this page to place the electromyography sensors.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCIN/10.13039/501100011033
Identifier Type: OTHER
Identifier Source: secondary_id
Parkinson-neuromodest-gifto
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.